Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05557006
Other study ID # GHNTC-PACE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 27, 2022
Est. completion date May 2024

Study information

Verified date March 2023
Source General Hospital of Shenyang Military Region
Contact Yanchun Liang, MD?PhD
Phone +86-13309886380
Email liangyanchun@sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Conduction system pacing (CSP), including His bundle pacing (HBP) and left bundle branch (LBB) pacing (LBBP), as a physiological pacing strategy, can achieve interventricular and/or intra-left ventricular mechanical synchronization by delivering physiological or nearly physiological ventricular activation. And many studies have verifed clinical efficacy of CSP that it can significantly relieve dyssynchrony of ventricular contraction, improve cardiac function and reduce the risk of heart failure as compared to right ventricular pacing. However, CSP has some shortcomings which limit its widespread application to some extent. As for HBP, although it can achieve optimal physiological ventricular synchronization, the problems of relatively high pacing threshold, low R-wave amplitude, the long-term performance, and inability to correct infra-Hisian atrioventricular block and intraventricular block in some patients have always been concerns. Nevertheless, LBBP is likely free of the restrictions mentioned above. On the contrary, LBBP can capture the left conduction system by directly stimulating the proximal LBB distal to the site of conduction block, thereby achieving rapid and physiological LV activation with a lower and stable pacing threshold and higher R-wave amplitude. However, as a newly emerged physiologic pacing technology, LBBP is currently in the exploratory stage and there are some phenomena to be interpreted, such as the evolution of pacing QRS morphology during the lead penetration into the interventricular septum. Therefore, the aim of this study is to assess the morphological evolution and electrophysiological characteristics of various pacing QRS patterns observed as the lead penetrates the interventricular septum from right to left.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The indications for pacemaker implantation are in accordance with the 2021 European Society of Cardiology (ESC) guidelines. - Patients requiring a high percentage of ventricular pacing (>40% expected ventricular pacing) include patients with advanced or third-degree atrioventricular block and atrial fibrillation with bradycardia. - Left bundle branch pacing will be performed. - Patients voluntarily participate and sign informed consent. Exclusion Criteria: - Atrioventricular block caused by reversible factors such as acute myocardial infarction and electrolyte disturbance. - Patients with severe liver or renal failure. - Life expectancy < 1 year. - Patients with age < 18 years. - Left ventricular ejection fraction (LVEF) < 40%.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
left bundle branch pacing
In the procedure of left bundle branch pacing, various QRS morphologies are observed as penetrating the lead into the interventricular septum.

Locations

Country Name City State
China General Hospital of Northern Theater Command Shenyang Liaoning

Sponsors (1)

Lead Sponsor Collaborator
General Hospital of Shenyang Military Region

Country where clinical trial is conducted

China, 

References & Publications (2)

Shimeno K, Tamura S, Nakatsuji K, Hayashi Y, Abe Y, Naruko T. Characteristics and proposed mechanisms of QRS morphology observed during the left bundle branch pacing procedure. Pacing Clin Electrophysiol. 2021 Dec;44(12):1987-1994. doi: 10.1111/pace.14382. Epub 2021 Oct 31. — View Citation

Zhang J, Sheng X, Pan Y, Wang M, Fu G. Electrophysiological Insights into Three Modalities of Left Bundle Branch Area Pacing in Patients Indicated for Pacing Therapy. Int Heart J. 2021 Jan 30;62(1):78-86. doi: 10.1536/ihj.20-490. Epub 2020 Dec 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Left ventricular activation time (LVAT) Left ventricular activation time (LVAT) is defined as the interval from the onset of the pacing stimulus to the peak of the R wave in lead V5/6, which reflects the lateral precordial myocardium depolarization time. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
Primary Right ventricular activation time (RVAT) Right ventricular activation time (RVAT) is defined as the interval from the onset of the pacing stimulus to the peak potential recorded by the atrial electrode temporarily placed in the right ventricle, which reflects delayed right ventricular activation. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
Primary Paced QRS morphology Paced QRS morphology during lead penetration through the interventricular septum mainly includes left bundle branch block, intraventricular block and right bundle branch block. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
Secondary Stimulus-QRSend duration (s-QRSend) Stimulus-QRSend duration (s-QRSend) is the time from the onset of the pacing stimulus to the end of QRS complex. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
Secondary The late-R wave duration and amplitude in lead V1 (r´dur?r´amp) The late-R wave duration in lead V1 indicates delayed right ventricular excitation. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
Secondary The S wave duration and amplitude in lead V6 (Sdur?Samp) The S wave duration in lead V6 indicates delayed right ventricular excitation. Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.
See also
  Status Clinical Trial Phase
Completed NCT04119323 - Image Location and Performance of Left Bundle Branch Pacing
Completed NCT00949715 - Optimize RV Follow-up Selective Site Pacing Clinical Trial N/A
Recruiting NCT04595487 - LVSP vs RVP in Patients With AV Conduction Disorders N/A
Terminated NCT00858559 - Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE) N/A
Completed NCT04023890 - Ventricular Electrical Synchronization by Stimulating Left and Right Bundle Branches Area in Pacing-indicated Patients
Completed NCT00621491 - Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation N/A
Completed NCT04738396 - Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
Completed NCT01755143 - Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment N/A